reference/31859631

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/31859631

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	78
issn	1366-5928 0049-8254
issueIdentifier	1
pageRange	65-78
publicationName	Xenobiotica; the fate of foreign compounds in biological systems
startingPage	65
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_4b711ffdbe8af5c8f3f9c53da46d83fa
bibliographicCitation	Zhang JYJ, Zhang J, Kiffe M, Walles M, Jin Y, Blanz J, Dayer J, Sanchez A, Zhang C, Zhang L, Huang Y, Oyang C. Preclinical pharmacokinetics and metabolism of MAK683, a clinical stage selective oral embryonic ectoderm development (EED) inhibitor for cancer treatment. Xenobiotica. 2022 Jan;52(1):65–78. doi: 10.1080/00498254.2021.2005852. PMID: 34761729.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b29d7bf7010f6f788f07387def69affb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9997a656d8f454e2e9932ea0b9bcb849 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ad419519f17d4e0255cde10d00d688d4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6edc60725c2db6516d9ea5515a7f4c18 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_56ee61c1b197bfb3eb3e03a702287f43 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5bca42fe9f000e3d86269a0799b86046 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b0139ca914a9c8d650e7714149b34ff6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c341988e8599008a45820ebade28cd23 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8bc08f74998cfc9c2ac2bebc859e697b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bba2ba3013821b5e008b0da59367a59f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5776ff35cfcd345d3d8fc74c4537190a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d9357b561e7a87395158d0c0cfabc916
date	2022-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/34761729 https://doi.org/10.1080/00498254.2021.2005852
isPartOf	https://portal.issn.org/resource/ISSN/0049-8254 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8102 https://portal.issn.org/resource/ISSN/1366-5928
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Preclinical pharmacokinetics and metabolism of MAK683, a clinical stage selective oral embryonic ectoderm development (EED) inhibitor for cancer treatment
discusses	http://id.nlm.nih.gov/mesh/M0499463 http://id.nlm.nih.gov/mesh/M0279147
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D009369 http://id.nlm.nih.gov/mesh/D004475
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D063151Q000378 http://id.nlm.nih.gov/mesh/D008252 http://id.nlm.nih.gov/mesh/D008862Q000378 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D051381 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D022781Q000378 http://id.nlm.nih.gov/mesh/D004285
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121412508 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a608a24ed70d4c1103ee78f2da5d69b4 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID145946138 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70934 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1117 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID177

Total number of triples: 53.